Rene Bernards, also affiliated with Oncode Institute, investigates the vulnerabilities of cancer cells with the aim of developing effective combination therapies for this condition. He is an acclaimed pioneer in this line of research, having developed a practice-changing therapy for intestinal cancer and several other combination therapies in clinical studies.
This is not Rene Bernards' first membership of a renowned scientific society. He is also a member and Academy Professor of the Royal Netherlands Academy of Arts and Sciences (KNAW). In 2020, Bernards was elected as member of the National Academy of Sciences (NAS) in the United States. In April 2019, he was elected as member of the American Academy of Arts and Sciences (AAAS), and in April 2018, as fellow of the AACR Academy of the American Association for Cancer Research.
“I feel very honored to receive this recognition by my British colleagues”, said Rene Bernards in response to the announcement. Rene Bernards has received various important awards for his work, including the Dutch Spinoza Prize and the Queen Wilhelmina research prize from the Dutch Cancer Society. Internationally, he received the Pezcoller Foundation award, the ESMO lifetime achievement award and the Ernst W. Bertner Award from the MDAnderson Cancer Center.
Drawn from across academia, industry and wider society, the new members spans disciplines as varied as pioneering treatments for Huntington’s Disease, developing the first algorithm for video streaming, generating new insights into memory formation, and studying the origins and evolution of our universe.
The Royal Society is a Fellowship of many of the world’s most distinguished scientists drawn from all areas of science, engineering, and medicine. The Society’s fundamental purpose, as it has been since its foundation in 1660, is to recognize, promote, and support excellence in science and to encourage the development and use of science for the benefit of humanity.